Tom Anderson, SwanBio Therapeutics CEO
Scoop: After failing to secure more funds, a private gene therapy developer lays off staff
Last Friday, SwanBio Therapeutics laid off about one-quarter of its 60-person workforce, a person with knowledge of the matter told Endpoints News.
The gene therapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.